Efficacy and safety of elranatamab (PF-06863135), a B-cell maturation antigen (BCMA)-CD3 bispecific antibody, in patients with relapsed or refractory multiple myeloma (MM).
暂无分享，去创建一个
A. Jakubowiak | S. Trudel | M. Tomasson | A. Lesokhin | N. Raje | K. Liao | M. Sebag | M. Chu | M. Solh | C. Basu | C. Costello | N. Bahlis | C. Gasparetto | A. Skoura | B. Dholaria | E. Chan | M. Levy | A. Dalovisio | Feng Liu | H. Dube | Feng Liu